Insider Transactions in Q3 2020 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2020
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
182
-100.0%
|
$12,376
$68.32 P/Share
|
|
Aug 15
2020
|
Merdad Parsey Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
182
+50.0%
|
$10,374
$57.43 P/Share
|
|
Aug 10
2020
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,384
-9.37%
|
$94,112
$68.51 P/Share
|
|
Aug 10
2020
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,345
+18.47%
|
-
|
|
Aug 10
2020
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,022
-6.53%
|
$69,496
$68.51 P/Share
|
|
Aug 10
2020
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,306
+12.83%
|
-
|
|
Jul 24
2020
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,587
-47.79%
|
$261,851
$73.64 P/Share
|
|
Jul 24
2020
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,505
+50.0%
|
-
|